11
May 2026
New photoacoustic imaging helps robotic surgeons avoid hidden anatomical hazards
Surgery is a complicated endeavor. Even a successful surgery can lead to complications, and even the best surgeons sometimes have unsuccessful surgeries.
Stay Informed!
11
May 2026
Diabetes, weight-loss drugs not a perfect fit?
Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide University, University of Oxford, ETH Zurich, and Stanford University, has found one in ten people may not be benefiting from common medications used to treat the condition.
11
May 2026
Study compares two antibiotics in treating severe hemorrhagic bacterial pneumonia
Stenotrophomonas maltophilia (S. maltophilia) is a multidrug-resistant bacterium that can cause severe and life-threatening hemorrhagic pneumonia in individuals with weakened immune systems.
11
May 2026
New CRISPR RNA scissors specifically target and destroy hepatitis E virus
An enzymatic scissors recognizes and cuts viral RNA, but leaves the host cell unharmed. This opens up new antiviral strategies against hepatitis E.
11
May 2026
Shaping the future of asthma management with the NObreath® at ATS 2026
World leaders in breath analysis Bedfont® Scientific Ltd. are pleased to be attending this years American Thoracic Society (ATS) International Conference, to exhibit the innovative NObreath® Fractional exhaled Nitric Oxide (FeNO) device at booth 1236 alongside its US distributor coVita™.
11
May 2026
Qureight establishes Scientific Advisory Board focused on pulmonary hypertension
Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has established a Scientific Advisory Board (SAB) focused on pulmonary hypertension (PH).
11
May 2026
FUJIFILM Biosciences and NextCell launch new commercial platform comprised of RUO stromal cells and cell culture media
FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company specializing in cell therapy using umbilical cord mesenchymal stromal cells (MSC), today announced a global commercial launch resulting from their strategic collaboration.
11
May 2026
Hovione and IDC Intranasal Drug Delivery Platform available for commercial partnerships
Hovione, a global integrated specialist CDMO, and Industrial Design Consultancy Ltd (IDC), an international product development company, today announced that their Intranasal Drug Delivery Platform has reached a new milestone, with its lead single-use nasal dry powder device now available for commercial partnerships.
11
May 2026
Uncountable expands specialty chemicals footprint with four new deals
Uncountable, a software company that develops AI platforms for end-to-end product development, today announced it has signed four new agreements with specialty chemicals organizations to support formulation development, scale-up, and production optimization.
11
May 2026
Nuclera launches antibody triage service to advance AI-driven antibody discovery
Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its antibody screening service to streamline the transition from antibody hit generation to lead selection.
